Rxcurve
HCPCS J3241 · per 10 MG

Inj. teprotumumab-trbw 10 mg

Products billed under this code include Tepezza.

Payment limit per 10 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.

Products billed under J3241

From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.

ProductLabelerNDCUnits / pkgLimit / pkg
Tepezza Amgen Inc 75987-0130-15 50 $19,081.35

Every quarter

QuarterPayment limitChangeBilling unitDescriptionSource file
4Q26 $381.627 +$1.727 10 MG Inj. teprotumumab-trbw 10 mg v1, posted September 17, 2026
3Q26 $379.90 +$11.992 10 MG Inj. teprotumumab-trbw 10 mg v1, posted September 15, 2026
2Q26 $367.908 −$1.404 10 MG Inj. teprotumumab-trbw 10 mg v1, posted September 15, 2026
1Q26 $369.312 +$10.12 10 MG Inj. teprotumumab-trbw 10 mg v1, posted September 15, 2026
4Q25 $359.192 +$0.103 10 MG Inj. teprotumumab-trbw 10 mg v1, posted September 8, 2026
3Q25 $359.089 +$6.526 10 MG Inj. teprotumumab-trbw 10 mg v1, posted March 10, 2026
2Q25 $352.563 +$5.461 10 MG Inj. teprotumumab-trbw 10 mg v1, posted March 10, 2026
1Q25 $347.102 +$3.217 10 MG Inj. teprotumumab-trbw 10 mg v1, posted December 19, 2025
4Q24 $343.885 +$7.745 10 MG Inj. teprotumumab-trbw 10 mg v1, posted June 11, 2025
3Q24 $336.14 +$2.739 10 MG Inj. teprotumumab-trbw 10 mg v1, posted June 11, 2025
2Q24 $333.401 +$5.403 10 MG Inj. teprotumumab-trbw 10 mg v1, posted March 11, 2025
1Q24 $327.998 $0.00 10 MG Inj. teprotumumab-trbw 10 mg v1, posted December 19, 2024
4Q23 $327.998 $0.00 10 MG Inj. teprotumumab-trbw 10 mg v1, posted October 10, 2024
3Q23 $327.998 $0.00 10 MG Inj. teprotumumab-trbw 10 mg v1, posted June 5, 2024
2Q23 $327.998 +$6.116 10 MG Inj. teprotumumab-trbw 10 mg v1, posted February 23, 2024
1Q23 $321.882 $0.00 10 MG Inj. teprotumumab-trbw 10 mg v1, posted December 6, 2023
4Q22 $321.882 +$0.512 10 MG Inj. teprotumumab-trbw 10 mg v1, posted June 22, 2023
3Q22 $321.37 +$5.49 10 MG Inj. teprotumumab-trbw 10 mg v1, posted June 9, 2023
2Q22 $315.88 $0.00 10 MG Inj. teprotumumab-trbw 10 mg v1, posted December 14, 2022
1Q22 $315.88 $0.00 10 MG Inj. teprotumumab-trbw 10 mg v1, posted June 8, 2022
4Q21 $315.88 $0.00 10 MG Inj. teprotumumab-trbw 10 mg v1, posted June 2, 2022
3Q21 $315.88 $0.00 10 MG Inj. teprotumumab-trbw 10 mg v1, posted June 2, 2022
2Q21 $315.88 $0.00 10 MG Inj. teprotumumab-trbw 10 mg v1, posted March 1, 2022
1Q21 $315.88 – 10 MG Inj. teprotumumab-trbw 10 mg v1, posted December 10, 2021

“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.

CMS source files